Correlation between Metabolic Syndrome and Cardiovascular Diseases: A Veterinary Perspective

A special issue of Animals (ISSN 2076-2615). This special issue belongs to the section "Veterinary Clinical Studies".

Deadline for manuscript submissions: closed (30 November 2024) | Viewed by 746

Special Issue Editor

Special Issue Information

Dear Colleagues,

The current Special Issue aims to gather high-quality papers that may contribute to our knowledge of metabolic syndrome in veterinary medicine, focusing on its effects on cardiovascular function.

Metabolic syndrome is a multifactorial condition with worldwide prevalence defined by the clustering of several factors including dysglycemia, obesity, high blood pressure, low high-density lipoprotein cholesterol (HDL-C), and elevated triglyceride levels that increase the risk of cardiovascular disease and diabetes mellitus type 2.

Due to the dissimilarity between species, animal models play a crucial role in better understanding the status of the disease and evaluating the underlying mechanisms involved in its pathophysiology.

Based on these premises, I am pleased to invite you to submit original papers, reviews, commentaries, and case reports addressing research and studies on the topic of understanding the biological mechanisms of metabolic syndrome and its cardiac pathological manifestation in animals. Please also note that the connection between the two topics, namely, metabolic syndrome and cardiovascular disease, should be proven using objective experimental data, not only statistics or bibliographic citations.

I look forward to receiving your contributions.

Prof. Dr. Michela Pugliese
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Animals is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • obesity
  • diabetes
  • dyslipidemia
  • hypertension
  • cardiovascular function
  • veterinary medicine

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

16 pages, 669 KiB  
Article
The Effects of Different Treatments on Serum Trace Element Levels in Dogs with Heart Failure
by Bengü Bilgiç, Duygu Tarhan and Mehmet Erman Or
Animals 2024, 14(23), 3390; https://doi.org/10.3390/ani14233390 - 25 Nov 2024
Viewed by 386
Abstract
The prognostic and diagnostic role of some trace elements in heart diseases has been demonstrated. In this study, the effects of min. 30-day and min. 120-day treatment with pimobendan, enalapril, and furosemide, as monotherapy and in combination, on serum trace element levels in [...] Read more.
The prognostic and diagnostic role of some trace elements in heart diseases has been demonstrated. In this study, the effects of min. 30-day and min. 120-day treatment with pimobendan, enalapril, and furosemide, as monotherapy and in combination, on serum trace element levels in dogs with heart failure were evaluated. A total of 107 dogs were treated with pimobendan or enalapril as monotherapy and pimobendan + enalapril (PE), enalapril + furosemide (EF), or pimobendan + enalapril + furosemide (PEF) as combination therapy for a min. of 30 and 120 days. Serum copper (Cu), zinc (Zn), iron (Fe), cobalt (Co), magnesium (Mg), manganese (Mn), selenium (Se), and chromium (Cr) were measured by an inductive coupled plasma optical emission spectroscopy device. Mean serum Mg in dogs treated with pimobendan for a min. of 120 days was significantly lower than that for a min. of 30 days (p < 0.05). In dogs using the PEF combination, mean serum Fe was significantly higher in the min. 120-day treatment group than in the min. 30-day treatment group (p < 0.01). No significant difference was observed in mean serum Cu, Zn, Co, Mn, Se, or Cr between the treatment groups and the time periods (p > 0.05). The short- and long-term use of pimobendan, enalapril, furosemide, and their combinations may cause changes in mean serum Mg and Fe in dogs with heart failure. Full article
Show Figures

Figure 1

Back to TopTop